CVD Prevention Journal Articles

• Cholesterol and CVD Events in Kidney Transplant Recipients Learn more about the potential association between remnant cholesterol and cardiovascular disease and all-cause mortality outcomes among individuals who had a kidney transplant.
  Nephrology Dialysis Transplantation, May 18, 2022
• Inflammation, Aging, and Cardiovascular Disease This review discusses recent advances regarding "inflamm-aging"; that is, age-dependent activation of inflammation and the pathways by which it influences the onset of cardiovascular disease.
  Journal of the American College of Cardiology, May 18, 2022
• Drug Dosing in Hospitalized Obese Patients With COVID-19 When making dosing decisions for the treatment of hospitalized COVID-19 patients with obesity, weight and BMI should be considered.
  Critical Care, May 11, 2022
• Prevalence of Primary Aldosteronism in T2D and Hypertension How prevalent is primary aldosteronism among patients with type 2 diabetes and hypertension? Should routine screening be considered for these patients?
  Clinical Endocrinology, May 05, 2022
• Acute Kidney Injury is Linked to Neurocognitive Impairments A new study finds that an episode of acute kidney injury could have negative impacts on neurocognitive functioning.
  Nephrology Dialysis Transplantation, May 04, 2022
• Pharmacologic Intervention Effects on Lipids and CRP in PCOS Could certain medications provide lipid and C-reactive protein improvements among women with PCOS?
  Clinical Endocrinology, April 28, 2022
• Why Are We Still Prescribing ACE Inhibitors? In this commentary, the authors suggest that the adverse effects of ACE inhibitors outweigh their usefulness, as better alternatives are now available.
  Circulation, April 28, 2022
• Association Between Thyroid Disorders and Arterial Stiffness Are thyroid hormone disorders associated with an increase in arterial stiffness? A new study investigates the possible link.
  Journal of the Endocrine Society, April 28, 2022
• Comorbidities in Women Living With HIV Gain a better understanding of the prevalence and impact of coexisting conditions among women living with HIV.
  HIV Medicine, April 21, 2022
• The Bi-directional Relationship of CVD and COVID-19 New studies are clarifying our understanding of the complex interplay between COVID-19 and cardiovascular disease.
  European Heart Journal, April 21, 2022
• When Statins Get Physical: A Curious Cause of Statin Myopathy Review the presentation of statin-induced necrotizing autoimmune myopathy, a rare, yet devastating complication of statin use.
  Southern Medical Journal, April 20, 2022
• SGLT2 Inhibitors: The Statins of the 21st Century This overview of the development and clinical applications of SGLT2 inhibitors positions them as one of the major pharmacological advances in cardiovascular medicine in this century.
  European Heart Journal, April 19, 2022
• Impact on Weight Gain With INSTI-Containing ART Regimens A new analysis finds that INSTI-based ART regimens may not be associated with accelerated rates of weight gain among treatment naive adults with HIV.
  HIV Medicine, April 07, 2022
• Type 2 Diabetes-Prevention Diet and Mortality Is adherence to a type 2 diabetes-prevention diet an effective strategy for improving longevity?
  American Journal of Epidemiology, April 06, 2022
• Lipid-Lowering Drug Therapy: A Critical Approach This review summarizes the main characteristics of statins, ezetimibe, and PCSK9 inhibitors as well as emerging lipid-lowering therapies which will further expand the available armamentarium.
  American Journal of Cardiovascular Drugs, April 04, 2022
• Measuring and Calculating Low-Density Lipoprotein Cholesterol This review examines the main methods currently used for routine LDL-C estimation, describing their pros, cons, and performance in different settings.
  American Journal of Clinical Pathology, March 29, 2022
• Interventions for Frailty Among Older Adults With CVD Review the various definitions of frailty, how frailty can be measured, and interventions to prevent, reverse, or slow the progression of frailty in patients with cardiovascular disease.
  Journal of the American College of Cardiology, March 25, 2022
• Characteristics, Comorbidities and Testosterone Prescribing Certain factors may impact the decision of whether or not to prescribe testosterone replacement therapy. What are they?
  Clinical Endocrinology, March 24, 2022
• Combination Lipid-lowering Therapy in Very High-risk Patients In this commentary, the authors make the case for treating all very high- and extremely high-risk patients with combination lipid-lowering therapy as the basic standard of care.
  European Heart Journal, March 23, 2022
• Cancer Survivorship and Subclinical Myocardial Damage What is the potential clinical significance of elevated high-sensitivity cardiac troponin T in cancer survivors?
  American Journal of Epidemiology, March 23, 2022